Article info

Download PDFPDF
Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?
  1. Correspondence to:
    Dr Mohan
    Department of Paediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77025, USA; suseela12hotmail.com
View Full Text

Citation

Mohan PV, Tarnow-Mordi W, Stenson B, et al
Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?

Publication history

  • Accepted December 8, 2002
  • First published January 1, 2004.
Online issue publication 
March 22, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.